Review Series: Chronic Myeloid Leukemia: An Update. Since 2014.

Guest Editors: Michele Baccarani and Fabrizio Pane

A CRITICAL HISTORY OF CHRONIC MYELOID LEUKEMIA
Michele Baccarani, Fabrizio Pane | DOI: 10.4084/mjhid.2014.010e2014010
CHRONIC MYELOGENOUS LEUKEMIA (CML) IN THE ELDERLY
Lodovico Balducci | DOI: 10.4084/mjhid.2014.037e2014037
 

Review Articles

Imatinib in Chronic Myeloid Leukemia: an Overview
Tomasz Sacha | DOI: 10.4084/mjhid.2014.007e2014007
MONITORING THE RESPONSE TO TYROSINE KINASE INHIBITOR (TKI) TREATMENT IN CHRONIC MYELOID LEUKEMIA (CML)
Ibrahim C. Haznedaroglu | DOI: 10.4084/mjhid.2014.009e2014009
TYROSINE KINASE INHIBITORS AND INTERFERON
Maria Dimou, Panagiotis Panagiotidis | DOI: 10.4084/mjhid.2014.006e2014006
SECOND-GENERATION TYROSINE KINASE INHIBITORS (TKI) AS SALVAGE THERAPY FOR RESISTANT OR INTOLERANT PATIENTS TO PRIOR TKIs
Massimo Breccia, Giuliana Alimena | DOI: 10.4084/mjhid.2014.003e2014003
TREATMENT RECOMMENDATIONS FOR CHRONIC MYELOID LEUKEMIA
Michele Baccarani, Fausto Castagnetti, Gabriele Gugliotta, Francesca Palandri, Gianantonio Rosti | DOI: 10.4084/mjhid.2014.005e2014005
TYROSINE KINASE INHIBITORS AND PREGNANCY
Elisabetta Abruzzese, Malgorzata Monika 
Trawinska, Paolo De Fabritiis, Alessio Pio Perrotti | DOI: 10.4084/mjhid.2014.028
e2014028
DRUG THERAPY IN THE PROGRESSED CML PATIENT WITH MULTI-TKI FAILURE 
Ibrahim C. Haznedaroglu | DOI: 10.4084/mjhid.2015.014


 
 
© PAGEPress 2008-2017     -     PAGEPress is a registered trademark property of PAGEPress srl, Italy.     -     VAT: IT02125780185